DESIGN THERAPEUTICS INC. - COMMON STOCK
5.6200
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.0500
+0.90%
Today's range
5.4700 - 5.8000
ISIN
N/A
Source
NASDAQ
-
Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
13 Nov 2024 07:00:49 By Nasdaq GlobeNewswire
-
07 Nov 2024 15:01:00 By Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
10 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
08 May 2024 15:05:01 By Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
07 May 2024 05:30:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 05:30:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
14 Aug 2023 15:05:00 By Nasdaq GlobeNewswire
-
14 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference
31 May 2023 05:30:00 By Nasdaq GlobeNewswire
-
Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
09 May 2023 15:05:01 By Nasdaq GlobeNewswire
-
24 Apr 2023 05:30:00 By Nasdaq GlobeNewswire
-
14 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
08 Feb 2023 05:30:00 By Nasdaq GlobeNewswire
-
07 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
17 Oct 2022 15:05:00 By Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
22 Sep 2022 05:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >